Aurobindo Pharma Delays 26% Stake Buy in Swarnaakshu Solar Over Pending Approvals
Hyderabad: Aurobindo Pharma Limited has deferred the completion timeline for its planned investment in Swarnaakshu Solar Power Private Limited, citing pending state government approval for setting up a captive solar power plant.
The company had earlier planned to enter into a captive solar power purchase agreement and acquire up to a 26% stake in Swarnaakshu by March 31, 2026. However, due to regulatory delays, the investment is now expected to be completed on or before June 30, 2026, subject to necessary approvals.
This move forms part of Aurobindo Pharma’s broader strategy to adopt renewable energy solutions and strengthen its sustainability initiatives through captive solar power sourcing.
The company has been consistently updating stock exchanges regarding this development through multiple communications issued on February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, and December 30, 2025.
The latest update has been formally submitted to both the National Stock Exchange of India Limited and BSE Limited.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.